Helen Usansky
Impact in
- Biochemistry top 10%
- Sulfur Compounds in Biology
- Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization
Papers in
- Oncology 7
- Drug Transport and Resistance Mechanisms 4
-
- Cystic Fibrosis Research Advances 2
- Pulmonary Hypertension Research and Treatments 2
- Co-authors
- Patrick J. Sinko (4 shared papers)Brahm Goldstein (2 shared papers)Edward A. Wintner (1 shared paper)Thomas L. Deckwerth (1 shared paper)Khurram Jamil (1 shared paper)Csaba Szabó (1 shared paper)Christopher F. Toombs (1 shared paper)Michael A. Insko (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)British Journal of Clinical Pharmacology (2 papers)Pharmaceutical Research (1 paper)Critical Care (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Helen Usansky
14 papers receiving 374 citations
Peers
Comparison fields: 5 of 80
- Biochemistry 77
- Immunology and Allergy 63
- Dermatology 84
- Pharmaceutical Science 37
- Endocrine and Autonomic Systems 35
Countries citing papers authored by Helen Usansky
This map shows the geographic impact of Helen Usansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Usansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Usansky more than expected).
Fields of papers citing papers by Helen Usansky
This network shows the impact of papers produced by Helen Usansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Usansky. The network helps show where Helen Usansky may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Usansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 106 | |
| 2 | 2019 | 101 | |
| 3 | 2005 | 52 | |
| 4 | 2008 | 28 | |
| 5 | 2004 | 25 | |
| 6 | 2012 | 23 | |
| 7 | 2021 | 19 | |
| 8 | 2022 | 13 | |
| 9 | 2003 | 12 | |
| 10 | 2019 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2018 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2025 | 0 |
About Helen Usansky
Helen Usansky is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pediatrics, Perinatology and Child Health and Epidemiology, having authored 16 papers that have together received 389 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Melanoma and MAPK Pathways (3 papers), Cystic Fibrosis Research Advances (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Computational Drug Discovery Methods (2 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Biochemistry (77 citations), Immunology and Allergy (63 citations), Dermatology (84 citations), Pharmaceutical Science (37 citations) and Endocrine and Autonomic Systems (35 citations). Helen Usansky has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Patrick J. Sinko, Brahm Goldstein, Edward A. Wintner, Thomas L. Deckwerth, Khurram Jamil, Csaba Szabó, Christopher F. Toombs, Michael A. Insko, Michael Cooreman and Peidi Hu. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Pharmacology and Experimental Therapeutics, British Journal of Clinical Pharmacology, Pharmaceutical Research and Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.